Health Policy Monitor
Skip Navigation

More info on Dr. Adam Oliver

Deputy Director of LSE Health and Social Care

London School of Economics and Political Science (LSE)
Houghton Street
London WC2A 2AE
United Kingdom

Phone: 020 7955 6471

Biography

A 2005-06 Commonwealth Fund Harkness Fellow in Health Care Policy, Adam holds a doctorate in economics from the University of Newcastle and an MSc in health economics from the University of York. Since 2001 he has worked at the London School of Economics, where he is currently Lecturer in Health Economics and Policy in the Department of Social Policy, and Senior Research Fellow and Deputy Director of LSE Health and Social Care, one of the largest research institutes in the health-related social sciences in Europe. He is a 1995-97 Japanese Ministry of Education (Monbusho) Research Scholar, Founding Chair of the Health Equity Network, Founding Coordinator of the Preference Elicitation Group, and a former Coordinator of the European Health Policy Group. He is also Founding Co-Editor of the journal, Health Economics, Policy and Law. He has published quite widely in the areas of health equity, economic evaluation, risk and uncertainty, and the economics and policy of European health care reform, and it is the interface between economics and political science in health care policy analysis that motivates his current principal research interests.

Publications

  1. Oliver, A., Maynard, A., and Mossialos, E. (forthcoming) Health Economics.
  2. Oliver, A., Mossialos, E. and Wilsford, D. Legacies and latitude in European health policy. The Journal of Health Politics, Policy and Law. Volume 30, Numbers 1-2, February-April.
  3. Oliver, A., Mossialos, E. and Robinson, R. (2004) Connecting technology assessment to priorities in health care, The International Journal of Technology Assessment in Health Care. Volume 20, Number 1, March.
  4. Oliver A, Mossialos E, Robinson R. (2004) Health technology assessment and its influence of health care priority setting. International Journal of Technology Assessment in Health Care; 20: 1-10.
  5. Oliver A. (2003) Health economic evaluation in Japan: a case study. Health Policy; 63(2): 197-204.
  6. Oliver A. (2003) A quantitative and qualitative test of the Allais paradox using health outcomes. Journal of Economic Psychology; 24: 35-48.
  7. Oliver A. (2003) Putting the quality into quality-adjusted life years. Journal of Public Health Medicine; 25: 8-12.
  8. Oliver A. (ed.) (2003) Health care priority setting: implications for health inequalities. Proceedings from a meeting of the Health Equity Network. London: The Nuffield Trust.
  9. Oliver A, Exworthy M. (eds.) (2003) Health inequalities: evidence, policy and implementation. Proceedings from a meeting of the Health Equity Network. London: The Nuffield Trust.
  10. Oliver A. (2003) Accounting for the missing opportunity costs in incremental cost-outcome analysis. Applied Health Economics and Health Policy; 1: 191-196.
  11. Oliver A. (2003) The internal consistency of the standard gamble: tests after adjusting for prospect theory. Journal of Health Economics; 22(4): 659-674.
  12. Oliver A. (2003) Testing rank-dependent expected utility theory in the context of health outcomes. Health Economics; 12(10): 863-871.
  13. Oliver A (ed.) (2003) Equity in health and health care: views from ethics, economics and political science. Proceedings from a meeting of the Health Equity Network. London: The Nuffield Trust.
  14. Oliver A, Nutbeam D. (2003) Addressing health inequalities in the UK: a case study. Journal of Public Health Medicine; 25: 281-287.
  15. Oliver A. (2003) Testing the internal consistency of the standard gamble in 'success' and 'failure' frames. Social Science and Medicine; 58, 2219-2229.
  16. Oliver A. (2002) At the end of the beginning: eliciting cardinal values for health states. London: LSE Health and Social Care Discussion Paper.
  17. Oliver A (ed.) (2002) International perspectives on equity and health: as seen from the UK. Proceedings from a meeting of the Health Equity Network. London: The Nuffield Trust.
  18. Oliver A, Healey A, Donaldson C. (2002) Choosing the method to match the perspective: economic evaluation and its implications for health services efficiency. The Lancet; 359: 1771-1774.
  19. Oliver A. (2002) Reforming public sector dentistry in the UK. British Journal of Health Care Management; 8(6): 212-216.
  20. Oliver A, McDaid D. (2002) Evidence-based health care: benefits and barriers. Social Policy and Society; 1(3): 183-190.
  21. Oliver A. (2002) Unintended consequences of applying economic evaluation. Journal of Health Services Research and Policy; 7(3): 129-130
  22. Oliver A, Healey A, Le Grand J. Addressing health inequalities. (2002) The Lancet 2002; 360: 565-567. (See also correspondence in The Lancet (2002); 360: November 23.
  23. Oliver A, Cookson R, McDaid D, Exworthy M. (2001) Developing a health equity network. Public Health; 115: 1-2.
  24. Oliver A. (2001) Why care about health inequality? London: Office of Health Economics.
  25. Oliver A. (2001) Increasing NHS funding: implications for welfare and justice. Journal of Public Health Medicine; 23(1): 7-10.
  26. Oliver A, Cookson R, McDaid D (eds) (2001) The Issues Panel for Equity in Health: the discussion papers. London: The Nuffield Trust.
  27. Oliver A. (2000) Uncertainty aversion: a reply to the paper by Andersson and Lyttkens. Health Economics; 9: 253-255.
  28. Oliver A, Pritchard C. (2000) Health economics of female longevity in the UK: economic evaluation in age related diseases. Journal of the British Menopause Society; 6: 61-65.
  29. Oliver A, Cookson R, McDaid D. (2000) A website initiative can help harness collaboration on health inequalities. Health Service Journal; October 19: 22-23.
  30. Oliver A, Cookson R. (2000) Towards multidisciplinary research into health inequalities. Health Economics; 9: 565-566.
  31. Oliver A, Pritchard C. (2000) Economic evaluations relating to diabetes: a descriptive review and their policy relevance. Value in Health; 3(6): 1-8.
  32. Oliver A. (2000) On health inequality. Journal of Public Health Medicine; 22(4): 454-456.
  33. Oliver A. (2000) Complete preferences over health states: a reply to the paper by Shiell et al. Health Economics; 9(8): 727-728.
  34. Oliver A, Ikegami N, Ikeda S. (1999) The Japanese government's pharmaceutical policy and its effect on hospital financial viability. Journal of Health Services Research and Policy; 4: 27-32.
  35. Oliver A. (1999) Risk adjusting health care resource allocations: theory and practice. London: Office of Health Economics.
  36. Oliver A, Ikegami N, Ikeda S. (1997) Japan's aging population: implications for healthcare. PharmacoEconomics; 11: 306-318.
  37. Oliver A, Ikeda S. (1997) An empirical comparison of the time preference rate; Japan and Norway. Healthcare and Society; 7: 128-142.
  38. Ikeda S, Ikegami N, Oliver A, Ikeda M. (1996) A case for the adoption of pharmacoeconomic guidelines in Japan. PharmacoEconomics; 10: 546-551.